Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice
暂无分享,去创建一个
Christian Weber | François Mach | Elisa A. Liehn | Alma Zernecke | A. Zernecke | C. Weber | F. Mach | S. Steffens | E. Liehn | K. Bidzhekov | E. Shagdarsuren | V. Braunersreuther | B. Luckow | Bruno Luckow | Sabine Steffens | Vincent Braunersreuther | Claire Arnaud | Erdenechimeg Shagdarsuren | Kiril Bidzhekov | Fabienne Burger | Graziano Pelli | G. Pelli | F. Burger | C. Arnaud
[1] F. Mach,et al. Leukocyte recruitment in atherosclerosis: Potential targets for therapeutic approaches? , 2006, Cellular and Molecular Life Sciences CMLS.
[2] C. Weber. Killing two birds with one stone: targeting chemokine receptors in atherosclerosis and HIV infection. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[3] T. Mosmann,et al. The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.
[4] Atsushi Mizoguchi,et al. Mice with a Selective Deletion of the CC Chemokine Receptors 5 or 2 Are Protected from Dextran Sodium Sulfate-Mediated Colitis: Lack of CC Chemokine Receptor 5 Expression Results in a NK1.1+ Lymphocyte-Associated Th2-Type Immune Response in the Intestine1 , 2000, The Journal of Immunology.
[5] Michael Ginsberg,et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Uguccioni,et al. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. , 2003, Blood.
[7] Z. Prohászka,et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. , 2001, Atherosclerosis.
[8] F. Ramsdell,et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.
[9] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[10] B. Rollins,et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[11] V. Álvarez,et al. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction , 2001, Genes and Immunity.
[12] R. Horuk,et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. , 2001, Blood.
[13] U. Andersson,et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.
[14] P. Sharp,et al. Involvement of CCR5 in the passage of Th1‐type cells across the blood‐retina barrier in experimental autoimmune uveitis , 2006, Journal of leukocyte biology.
[15] J. Witztum,et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Balling,et al. Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5‐deficient mice , 2004, European journal of immunology.
[17] A. Tedgui,et al. Role of Bone Marrow–Derived CC-Chemokine Receptor 5 in the Development of Atherosclerosis of Low-Density Lipoprotein Receptor Knockout Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[18] A. Zernecke,et al. Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[19] R. Alon,et al. Immune cell migration in inflammation: present and future therapeutic targets , 2005, Nature Immunology.
[20] Christian Weber,et al. Platelet Microparticles: A Transcellular Delivery System for RANTES Promoting Monocyte Recruitment on Endothelium , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[21] F. Mach,et al. Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice , 2004, Circulation research.
[22] J. Flores,et al. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non‐obese diabetic mice , 2004, European journal of immunology.
[23] Weixin Zhao,et al. Human Vascular Smooth Muscle Cells Possess Functional CCR5* , 2000, The Journal of Biological Chemistry.
[24] S. Szabo,et al. Molecular mechanisms regulating Th1 immune responses. , 2003, Annual review of immunology.
[25] N. Maeda,et al. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. , 2003, Atherosclerosis.
[26] A. Zernecke,et al. Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. , 2006, Blood.
[27] F. Mach,et al. Differential Expression Patterns of Proinflammatory and Antiinflammatory Mediators During Atherogenesis in Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[28] H. Broxmeyer,et al. Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1–Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1 , 1997, The Journal of experimental medicine.
[29] L. Demer,et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. , 1996, The Journal of clinical investigation.
[30] K. Ley,et al. RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium , 2001, Circulation.
[31] A. Tedgui,et al. Chemokine Receptor CCR1 Disruption in Bone Marrow Cells Enhances Atherosclerotic Lesion Development and Inflammation in Mice , 2005, Molecular medicine.
[32] Tatyana Chernova,et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease , 2002, Nature.
[33] T. Schall,et al. Local expression of inflammatory cytokines in human atherosclerotic plaques. , 1994, Journal of atherosclerosis and thrombosis.
[34] W. Kuziel,et al. The CC Chemokine Receptor 5 Is Important in Control of Parasite Replication and Acute Cardiac Inflammation following Infection with Trypanosoma cruzi , 2006, Infection and Immunity.
[35] A. Tedgui,et al. Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.
[36] Qingbo Xu. Role of heat shock proteins in atherosclerosis. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[37] Peter Libby,et al. The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.
[38] K. Matsushima,et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.
[39] R. Ransohoff,et al. The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.
[40] H. Fujiwara,et al. HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.